Special items: Ovarian Cancer and Us blog best viewed in Firefox

Wednesday, May 05, 2010

FDA Finalizes REMS Program for ESAs,; Amgen Continues to Study Risks -- limited information in text/article

Note: extract of article - limited information (requires subscription/$$)

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.